These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21084041)

  • 1. Appropriate use of oral drops: perception of health professionals and assessment of package insert information.
    Zaid AN; Al-Ramahi R; Abu Ghoush A
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):854-9. PubMed ID: 21084041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of dose-uniformity of samples delivered from paediatric oral droppers.
    Brown D; Ford JL; Nunn AJ; Rowe PH
    J Clin Pharm Ther; 2004 Dec; 29(6):521-9. PubMed ID: 15584940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The patient's understanding of the oral contraceptive patient package insert.
    Casey FG; Fluitt DM; Wiatt AL
    Mil Med; 1983 Mar; 148(3):276-8. PubMed ID: 6408516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiencies of product labeling directions for the preparation of radiopharmaceuticals.
    Hung JC; Ponto JA; Gadient KR; Frie JA; Aksamit CM; Enquist CL; Carrels KE
    J Am Pharm Assoc (2003); 2004; 44(1):30-5. PubMed ID: 14965150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitude and perception of patients and health care practitioners toward oral sustained release dosage forms in Palestine.
    Zaid AN
    Saudi Pharm J; 2010 Oct; 18(4):251-6. PubMed ID: 23960735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of consumers and healthcare professionals towards the patient package inserts - a study in Palestine.
    Al-Ramahi R; Zaid AN; Kettana N; Sweileh W; Al-Jabi D
    Pharm Pract (Granada); 2012 Jan; 10(1):57-63. PubMed ID: 24155818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The development and operation of a package inserts service system for electronic medical records].
    Yamada H; Nishimura S; Shimamori Y; Sato S; Hayase Y
    Yakugaku Zasshi; 2003 Mar; 123(3):201-9. PubMed ID: 12693022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the boxed warnings in package inserts of prescription medicines for medical professionals in Japan.
    Mino Y; Naito T; Ohshiro J; Yamada T; Kawakami J
    Pharm Pract (Granada); 2022; 20(4):2733. PubMed ID: 36793916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals.
    Mühlbauer V; Mühlhauser I
    BMC Health Serv Res; 2015 Nov; 15():505. PubMed ID: 26554666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward the patient package insert--a survey of physicians and pharmacists.
    Fleckenstein L
    Drug Inf J; 1977; 11(1):23-9. PubMed ID: 10304966
    [No Abstract]   [Full Text] [Related]  

  • 13. Current oral contraceptive use instructions: an analysis of patient package inserts.
    Williams-Deane M; Potter LS
    Fam Plann Perspect; 1992; 24(3):111-5. PubMed ID: 1628713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual medication management system (IMMS) implementation in pharmacists' opinion.
    Waszyk-Nowaczyk M; Lawicki S; Michalak M; Simon M
    Acta Pol Pharm; 2014; 71(3):509-14. PubMed ID: 25265831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding of definition and safety of oral health products among patients, physicians and pharmacists.
    Asahina Y; Hori S; Sawada Y
    Yakugaku Zasshi; 2010 Jul; 130(7):961-9. PubMed ID: 20606376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Questionnaire survey about NSAIDs use in late pregnancy for pharmacists and physicians].
    Tanaka S; Asahina Y; Satoh H; Miki A; Hori S; Sawada Y
    Yakugaku Zasshi; 2014; 134(6):757-66. PubMed ID: 24882653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instructions provided by manufacturers for proper use of nonprescription ophthalmic drops.
    Lisi DM; Fazio A
    Am J Hosp Pharm; 1991 May; 48(5):987-8. PubMed ID: 1853881
    [No Abstract]   [Full Text] [Related]  

  • 18. Knowledge, attitudes and practices of community pharmacists on generic medicines in Palestine: a cross-sectional study.
    Shraim NY; Al Taha TA; Qawasmeh RF; Jarrar HN; Shtaya MAN; Shayeb LA; Sweileh WM
    BMC Health Serv Res; 2017 Dec; 17(1):847. PubMed ID: 29282055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishing a System for Effectively Explaining Indications for Driving Prohibition Contained in Drug Package Inserts].
    Tanaka M
    Yakugaku Zasshi; 2017; 137(3):337-340. PubMed ID: 28250330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.